Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
The study will have blood pressure measurements, physical exams, blood draws, urine collection including 24 hour urine collection, quality of life surveys and study drug/placebo intravenous infusion. You will also need to be vaccinated against some specific diseases.
information provided upon request, mileage reimbursement
Clinical or Medical
Kidneys and Liver